Primary Site >> Pancreatic Cancer
Gene >> PIK3CG
| 1. | |||||||||||
| Journal: | J Exp Clin Cancer Res. 2008 Nov 25;27:76. | ||||||||||
| Title: | Modulating effect of the PI3-kinase inhibitor LY294002 on cisplatin in human pancreatic cancer cells. | ||||||||||
| Author: | Fujiwara, Masao|Izuishi, Kunihiko|Sano, Takanori|Hossain, Mohammad Akram|Kimura, Shoji|Masaki, Tsutomu|Suzuki, Yasuyuki | ||||||||||
| PMID: | 19032736 | ||||||||||
| 2. | |||||||||||
| Journal: | Cancer Biol Ther. 2010 Sep 15;10(6):582-7. Epub 2010 Oct 1. | ||||||||||
| Title: | Prioritization of driver mutations in pancreatic cancer using cancer-specific high-throughput annotation of somatic mutations (CHASM). | ||||||||||
| Author: | Carter, Hannah|Samayoa, Josue|Hruban, Ralph H|Karchin, Rachel | ||||||||||
| PMID: | 20581473 | ||||||||||
| 3. | |||||||||||
| Journal: | JOP. 2011 Jul 8;12(4):334-8. | ||||||||||
| Title: | Novel agents for the treatment of pancreatic adenocarcinoma. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011. | ||||||||||
| Author: | Cheng, Haiying|Merika, Eirini|Syrigos, Kostas N|Saif, Muhammad Wasif | ||||||||||
| PMID: | 21737890 | ||||||||||
| 4. | |||||||||||
| Journal: | Clin Cancer Res. 2012 Apr 1;18(7):2048-55. | ||||||||||
| Title: | Phase I study of Rigosertib, an inhibitor of the phosphatidylinositol 3-kinase and Polo-like kinase 1 pathways, combined with gemcitabine in patients with solid tumors and pancreatic cancer. | ||||||||||
| Author: | Ma, Wen Wee|Messersmith, Wells A|Dy, Grace K|Weekes, Colin D|Whitworth, Amy|Ren, Chen|Maniar, Manoj|Wilhelm, Francois|Eckhardt, S Gail|Adjei, Alex A|Jimeno, Antonio | ||||||||||
| PMID: | 22338014 | ||||||||||
| 5. | |||||||||||
| Journal: | Cancer Biol Ther. 2014 May;15(5):524-32. | ||||||||||
| Title: | Caffeine and the analog CGS 15943 inhibit cancer cell growth by targeting the phosphoinositide 3-kinase/Akt pathway. | ||||||||||
| Author: | Edling, Charlotte E|Selvaggi, Federico|Ghonaim, Ragheda|Maffucci, Tania|Falasca, Marco | ||||||||||
| PMID: | 24521981 | ||||||||||
| 6. | |||||||||||
| Journal: | Cancer Lett. 2014 Oct 10;353(1):68-77. | ||||||||||
| Title: | Anticancer activity of HS-527, a novel inhibitor targeting PI3-kinase in human pancreatic cancer cells. | ||||||||||
| Author: | Ryu, Ye-Lim|Jung, Kyung Hee|Son, Mi Kwon|Yan, Hong Hua|Kim, Soo Jung|Shin, Sanghye|Hong, Sungwoo|Hong, Soon-Sun | ||||||||||
| PMID: | 25016056 | ||||||||||
| 7. | |||||||||||
| Journal: | Front Physiol. 2014 Oct 15;5:391. | ||||||||||
| Title: | Targeting p110gamma in gastrointestinal cancers: attack on multiple fronts. | ||||||||||
| Author: | Falasca, Marco|Maffucci, Tania | ||||||||||
| PMID: | 25360116 | ||||||||||
| 8. | |||||||||||
| Journal: | Mol Cancer Ther. 2015 Jan;14(1):40-7. | ||||||||||
| Title: | Modeling targeted inhibition of MEK and PI3 kinase in human pancreatic cancer. | ||||||||||
| Author: | Junttila, Melissa R|Devasthali, Vidusha|Cheng, Jason H|Castillo, Joseph|Metcalfe, Ciara|Clermont, Anne C|Otter, Douglas Den|Chan, Emily|Bou-Reslan, Hani|Cao, Tim|Forrest, William|Nannini, Michelle A|French, Dorothy|Carano, Richard|Merchant, Mark|Hoeflich, | ||||||||||
| PMID: | 25376606 | ||||||||||
| 9. | |||||||||||
| Journal: | Clin Cancer Res. 2016 Dec 1;22(23):5805-5817. | ||||||||||
| Title: | Therapeutic Benefit of Selective Inhibition of p110alpha PI3-Kinase in Pancreatic Neuroendocrine Tumors. | ||||||||||
| Author: | Soler, Adriana|Figueiredo, Ana M|Castel, Pau|Martin, Laura|Monelli, Erika|Angulo-Urarte, Ana|Mila-Guasch, Maria|Vinals, Francesc|Baselga, Jose|Casanovas, Oriol|Graupera, Mariona | ||||||||||
| PMID: | 27225693 | ||||||||||
| 10. | |||||||||||
| Journal: | Cancer Genet. 2016 Dec;209(12):567-581. | ||||||||||
| Title: | Molecular targeted therapy for pancreatic adenocarcinoma: A review of completed and ongoing late phase clinical trials. | ||||||||||
| Author: | Mosquera, Catalina|Maglic, Dino|Zervos, Emmanuel E | ||||||||||
| PMID: | 27613577 | ||||||||||
| 11. | |||||||||||
| Journal: | Int J Oncol. 2017 Jun;50(6):2049-2058. | ||||||||||
| Title: | Clinical significance of Akt2 in advanced pancreatic cancer treated with erlotinib. | ||||||||||
| Author: | Banno, Eri|Togashi, Yosuke|de Velasco, Marco A|Mizukami, Takuro|Nakamura, Yu|Terashima, Masato|Sakai, Kazuko|Fujita, Yoshihiko|Kamata, Ken|Kitano, Masayuki|Kudo, Masatoshi|Nishio, Kazuto | ||||||||||
| PMID: | 28440469 | ||||||||||
| 12. | |||||||||||
| Journal: | Oncol Lett. 2018 Feb;15(2):2105-2110. | ||||||||||
| Title: | Notch signaling via regulation of RB and p-AKT but not PIK3CG contributes to MIA PaCa-2 cell growth and migration to affect pancreatic carcinogenesis. | ||||||||||
| Author: | Zhang, Shubing|Liu, Jingjiang|Xu, Keli|Li, Zhijian | ||||||||||
| PMID: | 29434912 | ||||||||||